Search

everythinglearnresearchcommunity

for

Search:↓

Standardized PRP is effective for tendinopathies, with most patients improving after one injection.

Rogaine can stop hair loss in women, and other treatments like certain pills, light therapy, and special shampoos may also work.

Future treatments for hair loss may focus on personalized and regenerative approaches.

Androgenetic alopecia treatments focus on reducing hair loss by targeting hormones, with new therapies showing promise but needing more research.

New treatments for alopecia show promise in restoring hair growth by targeting immune and hormonal factors.

Androgenic alopecia, a common hair loss condition, is linked to changes in androgen metabolism and genetics, and can be treated with finasteride and minoxidil, but these treatments are only fully effective in 10% of patients.

Better understanding of wound healing is needed to develop effective treatments for chronic wounds.

Individualized treatment and support can help most couples with recurrent implantation failure achieve pregnancy.

Mechanical stimulation and new therapies show promise for hair regrowth.

PDRN from trout sperm helps skin and hair regeneration but is costly and complex to produce.

Combining minoxidil with other treatments like finasteride or PRP improves hair growth and satisfaction more than using minoxidil alone.

New regenerative medicine-based therapies for hair loss look promising but need more clinical validation.

New understanding and treatments for hair loss are improving, but more research is needed.

Minoxidil is the only FDA-approved treatment for female hair loss, with other potential treatments needing more research for effectiveness.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Hair loss can be treated with common methods like minoxidil and finasteride, but new potential treatments include growth factors, cytokines, and platelet-rich plasma injections.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

Reduced sexual drive may be linked to male breast cancer, while anti-estrogenic factors might lower the risk.

Women with severe acne, hirsutism, and androgenic alopecia often have higher levels of certain androgens, but the specific pattern can't be predicted just by looking at symptoms.

Finasteride treatment changes brain steroid levels and receptors, affecting brain function even after stopping treatment.

Tamoxifen can cause total hair loss but its benefits outweigh this side effect.

Africa's low COVID-19 rates may be linked to early measures and possibly higher estrogen levels in women.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

Flutamide combined with an LHRH agonist effectively inhibits prostate growth, suggesting it could treat prostate cancer.

Spironolactone treatment increases the amount of testosterone available in the body.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

A woman's male-like symptoms and high testosterone were due to ovarian hilus-cell hyperplasia, which improved after surgery.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.